Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Peele: Diabetes in employer-sponsored health insurance. (0.08 sec) 

Diabetes in employer-sponsored health insurance

- Free from Publisher
PB Peele, JR Lave, TJ Songer - Diabetes care, 2002 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Health insurance billing data for ∼1.3 million
individuals enrolled in health insurance plans sponsored by 862 large
self-insured employers nationwide were used to examine employer ...
Cited by 8 - Related articles - BL Direct - All 5 versions

[CITATION] Translating Research Into Action for Diabetes Study Group


AJ Karter, MR Stevens, WH Herman, S Ettner, … - Out-of-pocket costs and diabetes preventive services: …, 2003
Cited by 3 - Related articles

Does mandated diabetes coverage boost compliance?


WJ Guglielmo, 2001 - medec.com
Eric J. Wedell is one of those doctors whose influence extends beyond the exam
room. This year, the Cheyenne, WY, endocrinologist joined forces with a regional
representative of the American Diabetes Association to push through the ...
Cited by 3 - Related articles - Cached - All 2 versions

[PDF] Angst vor Insulintherapie bei Typ-2-Diabetikern


A Scholze - ub.uni-bamberg.de
Page 1. Angst vor Insulintherapie bei Typ-2-Diabetikern Inaugural-Dissertation
in der Fakultät Pädagogik, Philosophie und Psychologie ...
Related articles - View as HTML - All 3 versions

The Opportunity at Pitney Bowes


A Forms - Am J Manag Care, 2005 - ajmc.com
Concerned about rising prevalence and costs of diabetes among its employees,
Pitney Bowes Inc recently revamped its drug benefit design to synergize with
ongoing efforts in its disease management and patient education programs. ...
Related articles - Cached - All 2 versions

Cost of diabetes-related complications: current issues, future directions


K Summers, TJ Songer - Expert Review of Pharmacoeconomics and Outcomes …, 2003 - ingentaconnect.com
The costs of diabetes are significant, approaching US$100 billion. Medical costs
for patients with diabetes are between two- and four-times higher per patient
per year when compared to persons without diabetes. Long-term complications ...
Related articles - All 3 versions

The Opportunity at Pitney Bowes


A Follow - Am J Manag Care, 2005 - ajmc.com
Concerned about rising prevalence and costs of diabetes among its employees,
Pitney Bowes Inc recently revamped its drug benefit design to synergize with
ongoing efforts in its disease management and patient education programs. ...
Related articles - Cached

A Micro Analysis of The Effect of Insurance Mandates on the Behavior of Diabetics: …

- gmu.edu [PDF] 
J Klick, T Stratmann - papers.ssrn.com
Abstract: In the face of rising diabetes rates, many states passed laws
requiring health insurance plans to cover medical treatments for the disease. As
with most insurance, this coverage has the potential to induce moral hazard ...
Related articles - All 3 versions

Diabetic risk taking: The role of information, education and medication


ME Kahn - Journal of Risk and Uncertainty, 1999 - Springer
Diet adherence is a key determinant in minimizing the risk of diabetic health
complications. Diabetics who ignore their doctor's advice, concerning diet,
smoking and exercise, are taking a gamble. Food product innovation, ...
Cited by 10 - Related articles - BL Direct - All 6 versions

Insulin for the world's poorest countries


E Chantelau - The Lancet, 2000 - Elsevier
John Yudkin 1 politely failed to mention that the world's poorest countries
cannot afford insulin, because of rising prices of the products of the world's
richest insulin manufacturers (Lilly, NovoNordisk, and Hoechst/Aventis) ...
Cited by 1 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google